Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer
Cancers · 21.01.2023 · 15 (3) · 672
DOI: 10.3390/cancers15030672 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 21.01.2023. Verfasst von Yuan James Rao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Oncology, The George Washington University School of Medicine, Washington, DC 20037, USA. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) have a poor prognosis, with a significant risk of progression or death despite multimodal treatment with surgery, chemotherapy, and radiotherapy. Immune checkpoint inhibitors targeting the programmed death receptor-1 (PD1) have dramatically changed the treatment landscape for recurrent/metastatic disease, improving overall survival in both the first- and second-line palliative settings. This success has driven the investigation of treatment strategies incorporating immunotherapy earlier into the multimodal curative-intent or salvage treatment of both locally advanced and recurrent/metastatic HNSCC. This review encompassed the following three subjects, with a focus on recently reported and ongoing clinical trials: (1) the use of neoadjuvant immunotherapy prior to surgery for locally advanced HNSCC, (2) the use of immunochemoradiotherapy for locally advanced head and neck cancers, and (3) novel uses of immunotherapy in the salvage of recurrent/metastatic HNSCC via a combined modality, including reirradiation paradigms. The results of these studies are eagerly awaited to improve patient outcomes in this challenging disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Radiation Oncology, The George Washington University School of Medicine, Washington, DC 20037, USA.
- Division of Head and Neck Surgery, The George Washington University School of Medicine, Washington, DC 20037, USA.
- Division of Hematology/Oncology, The George Washington University School of Medicine, Washington, DC 20037, USA.
ORCID-Profile: Yuan James Rao, Joseph F Goodman, Julie E Bauman
Zitieren
APA
Rao, Y. J., Goodman, J. F., Haroun, F., & Bauman, J. E. (2023). Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer. Cancers, 15(3), 672. https://doi.org/10.3390/cancers15030672
Vancouver
Rao YJ, Goodman JF, Haroun F, Bauman JE. Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer. Cancers. 2023;15(3):672. doi:10.3390/cancers15030672
BibTeX
@article{Rao2023,
author = {Rao, Yuan James and Goodman, Joseph F and Haroun, Faysal and Bauman, Julie E},
title = {Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {672},
doi = {10.3390/cancers15030672}
}
EUVIMED